These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31382680)

  • 1. Effects of the Japanese Encephalitis Virus Genotype V-Derived Sub-Viral Particles on the Immunogenicity of the Vaccine Characterized by a Novel Virus-Like Particle-Based Assay.
    Honjo S; Masuda M; Ishikawa T
    Vaccines (Basel); 2019 Aug; 7(3):. PubMed ID: 31382680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence and Cross-Protection Conferred by an Attenuated Genotype I-Based Chimeric Japanese Encephalitis Virus Strain Harboring the E Protein of Genotype V in Mice.
    Xia Q; Zhang Y; Yang Y; Ma X; Guan Z; Zhang J; Li Z; Liu K; Li B; Shao D; Qiu Y; Wei J; Ma Z
    Microbiol Spectr; 2022 Dec; 10(6):e0199022. PubMed ID: 36301111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus.
    Kim JD; Lee AR; Moon DH; Chung YU; Hong SY; Cho HJ; Kang TH; Jang YH; Sohn MH; Seong BL; Seo SU
    Emerg Microbes Infect; 2024 Dec; 13(1):2343910. PubMed ID: 38618740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV.
    Tajima S; Taniguchi S; Nakayama E; Maeki T; Inagaki T; Saijo M; Lim CK
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain.
    Tajima S; Yagasaki K; Kotaki A; Tomikawa T; Nakayama E; Moi ML; Lim CK; Saijo M; Kurane I; Takasaki T
    J Gen Virol; 2015 Sep; 96(9):2661-2669. PubMed ID: 26048886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Japanese Encephalitis Virus Genotype V in Republic of Korea.
    Lee AR; Song JM; Seo SU
    J Microbiol Biotechnol; 2022 Aug; 32(8):955-959. PubMed ID: 35879275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Japanese encephalitis virus genotype V virus-like particle vaccine in silkworms.
    Nerome K; Yamaguchi R; Fuke N; Izzati UZ; Maegawa K; Sugita S; Kawasaki K; Kuroda K; Nerome R
    J Gen Virol; 2018 Jul; 99(7):897-907. PubMed ID: 29877787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
    Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shift in dominant genotypes of Japanese encephalitis virus and its impact on current vaccination strategies.
    Xia Q; Yang Y; Zhang Y; Zhou L; Ma X; Xiao C; Zhang J; Li Z; Liu K; Li B; Shao D; Qiu Y; Wei J; Ma Z
    Front Microbiol; 2023; 14():1302101. PubMed ID: 38045034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Neutralizing Antibody Titers against Japanese Encephalitis Virus Genotype V Strain with Those against Genotype I and III Strains in the Sera of Japanese Encephalitis Patients in Japan in 2016.
    Maeki T; Tajima S; Kyaw AK; Matsumoto F; Miura K; Yamashita A; Yoshikawa A; Negishi K; Noguchi Y; Tadokoro K; Abe K; Taruya J; Koh J; Ito H; Ikegaya A; Abe F; Wada M; Nishigata T; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Morita K; Lim CK; Saijo M
    Jpn J Infect Dis; 2018 Sep; 71(5):360-364. PubMed ID: 29962489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization Potency of Sera from Vietnamese Patients with Japanese Encephalitis (JE) against Genotypes I and V JE Viruses.
    Nguyen TTT; Tajima S; Ikeda M; Nguyen TT; Le TTH; Pham HTT; Pham DQ; Le MTQ; Maeki T; Taniguchi S; Kato F; Moi ML; Morita K; Lim CK; Saijo M; Hasebe F
    Jpn J Infect Dis; 2019 Mar; 72(2):115-117. PubMed ID: 30381682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino Acid at Position 166 of NS2A in Japanese Encephalitis Virus (JEV) is Associated with In Vitro Growth Characteristics of JEV.
    Tajima S; Taniguchi S; Nakayama E; Maeki T; Inagaki T; Lim CK; Saijo M
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice.
    Tajima S; Shibasaki KI; Taniguchi S; Nakayama E; Maeki T; Lim CK; Saijo M
    Heliyon; 2019 Nov; 5(11):e02882. PubMed ID: 31799464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs.
    de Wispelaere M; Ricklin M; Souque P; Frenkiel MP; Paulous S; Garcìa-Nicolàs O; Summerfield A; Charneau P; Desprès P
    PLoS Negl Trop Dis; 2015; 9(10):e0004081. PubMed ID: 26437302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth, Pathogenesis, and Serological Characteristics of the Japanese Encephalitis Virus Genotype IV Recent Strain 19CxBa-83-Cv.
    Tajima S; Maeki T; Nakayama E; Faizah AN; Kobayashi D; Isawa H; Maekawa Y; Bendryman SS; Mulyatno KC; Rohmah EA; Mori Y; Sawabe K; Ebihara H; Lim CK
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.
    Bielefeldt-Ohmann H; Prow NA; Wang W; Tan CS; Coyle M; Douma A; Hobson-Peters J; Kidd L; Hall RA; Petrovsky N
    Vet Res; 2014 Dec; 45(1):130. PubMed ID: 25516480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus.
    Saga R; Fujimoto A; Watanabe N; Matsuda M; Hasegawa M; Watashi K; Aizaki H; Nakamura N; Tajima S; Takasaki T; Konishi E; Kato T; Kohara M; Takeyama H; Wakita T; Suzuki R
    Sci Rep; 2016 Jun; 6():28688. PubMed ID: 27345289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
    Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X
    Virol J; 2015 Dec; 12():214. PubMed ID: 26651827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secreted expression of Japanese encephalitis virus prME in Pichia pastoris and immunogenicity evaluation of the virus-like particles in mice].
    Zhao P; Jiang Y; Wang J; Fan H; Cao R
    Sheng Wu Gong Cheng Xue Bao; 2017 May; 33(5):863-874. PubMed ID: 28876040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.